Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon

許仁毓 (Jen-Yu Hsu)


  • 學歷
    • 國立陽明交通大學 環境與職業衛生研究所 碩士
    • 國立臺灣大學 醫學系 學士
  • 經歷
    • 2023- 迄今 臺北榮民總醫院 職業醫學及臨床毒物部 主治醫師
    • - 迄今 國立陽明交通大學 醫學系 兼任講師
    • - 衛生福利部 疾病管制署 防疫醫師
    • - 臺中榮民總醫院 內科部 感染科 總醫師
    • - 國立臺灣大學醫學院附設醫院 內科部 感染科 總醫師
    • - 臺北榮民總醫院 內科部 臨床毒物與職業醫學科 總醫師
    • - 國立成功大學醫學院附設醫院 內科部 住院醫師
  • 醫療專長
    1. 職業醫學
    2. 臨床毒物學
    3. 感染症醫學
  • 證照
    職業醫學專科醫師 感染症專科醫師 內科專科醫師
  • 語言專長
    中文 英文 臺語


項目 作者 文章標題 期刊
1 Hsu JY, Chu FY, Wang PH, Wu ML Unusual hard metal lung disease: bronchiolocentric interstitial pneumonia. Occup Med (Lond). 2024 May 3:kqae030.
2 Hsu JY, Chiang SO, Yang CC, Mao YC A Nationwide Study on the Risks of Complications and Healthcare Costs of Snakebite Envenomation in Taiwan. Am J Trop Med Hyg. 2024 May 7:tpmd240030.
3 Hsieh CY, Hsu JY, Yang CC. Predictive factors for severe outcomes in substance abuse-related emergency visits: A 5-year retrospective analysis at a medical center in Taiwan. J Chin Med Assoc. 2024 Jan 1;87(1):40-47.
4 Hsu JY, Sun HY, Chen LY, Chang SY, Chuang YC, Huang YS, Su YC, Liu WC, Hung CC. Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide. J Glob Antimicrob Resist. 2024 Mar;36:426-435.
5 Hsu JY, Hung CC, Tsou TP, Chen WC. Epidemiology and risk factors of Japanese encephalitis in Taiwan, 2010-2022. PLoS Negl Trop Dis. 2023 Oct 2;17(10):e0011421.
6 Hsu JY, Chiang SO, Yang CC, Hsieh TW, Chung CJ, Mao YC. Nationwide and long-term epidemiological research of snakebite envenomation in Taiwan during 2002-2014 based on the use of snake antivenoms: A study utilizing National Health Insurance Database. PLoS Negl Trop Dis. 2023 Jun 8;17(6):e0011376.
7 Hsu JY, Sun HY, Hsieh TW, Chang SY, Chuang YC, Huang YS, Hsiao CY, Su YC, Liu WC, Chang SF, Hung CC Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapy. J Glob Antimicrob Resist. 2022 Jun;29:7-16.
8 Hsu JY, Cheng A, Ku CC, Chen YC, Wang JT, Hsieh TW, Sheng WH, Chang SC, Wu UI Mycobacterium abscessus and Mycobacterium massiliense exhibit distinct host and organ specificity: a cross-sectional study. Int J Infect Dis. 2022 Mar;116:21-26.
9 Hsu JY, Liu PY, Tseng CH, Liu CW, Yang WT, Huang WH, Li SY, Liao YC, Wu MJ COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting. J Multidiscip Healthc. 2021 Oct 27;14:3027-3034.
10 Hsu JY, Mao YC, Liu PY, Lai KL Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19. Pharmaceuticals (Basel). 2021 Sep 23;14(10):955.
11 Hsu JY, Chuang YC, Wang JT, Chen YC, Hsieh SM Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019. J Formos Med Assoc. 2021 Nov;120(11):1994-2002.